Lung Cancer Panel tests in Dubai & UAE

Compare available Lung Cancer Panel tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

1,600.00–15,600.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Lung Cancer Panel test prices

Showing 1–6 of 6 matching tests.

Lung Cancer Panel diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-2060 Immunohistochemistry Lung Non-Small Cell Carcinoma (NSCC) Panel Test This test identifies key protein markers (ALK, ROS1, PD-L1, EGFR) in lung tumour tissue using immunohistochemistry to guide targeted therapy.	Formalin-Fixed Paraffin-Embedded (FFPE) Tumour Tissue Block or Archival Surgical Pathology Cuts	FFPE Block: 5 days; Large complex tissue: 7 days	2,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ALK protein expression", "ROS1 protein expression", "PD-L1 protein expression", "EGFR protein expression"] Parameters [] Preparation ["No fasting is needed", "Provide original histopathology report, biopsy site details, and complete clinical history"] Indications ["Diagnosis of Non-Small Cell Lung Carcinoma (NSCLC)", "Guiding targeted therapy selection for NSCLC"] Measurement technique Confirm with laboratory Codes LOINC: 104282-4 ICD-10: C34.90 Clinical summary This test identifies key protein markers (ALK, ROS1, PD-L1, EGFR) in lung tumour tissue using immunohistochemistry to guide targeted therapy.
TEST-1417 Lung Cancer Panel 6 (EGFR Sequencing, ALK IHC, ROS1 FISH) Test This diagnostic test evaluates for specific genetic mutations and rearrangements in lung cancer tissue relevant to targeted therapy.	FFPE Tumor Tissue (Archival specimen)	5 – 7 working days	4,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["EGFR mutations", "ALK rearrangements", "ROS1 fusions"] Parameters [{"name": "EGFR Mutations", "reference_range": null}, {"name": "ALK Rearrangements", "reference_range": null}, {"name": "ROS1 Fusions", "reference_range": null}] Preparation ["No fasting required", "Sample is a tumor tissue biopsy obtained previously"] Indications ["Confirmed histological diagnosis of primary non-small cell lung carcinoma (NSCLC)", "Need for targeted therapy selection"] Measurement technique Confirm with laboratory Codes LOINC: 94498-6 ICD-10: C34.9 Clinical summary This diagnostic test evaluates for specific genetic mutations and rearrangements in lung cancer tissue relevant to targeted therapy.
TEST-1413 Lung Cancer Panel 8 (EGFR, BRAF, ALK, ROS1, MET, PD‑L1) Test This test identifies specific genetic mutations and protein expressions in lung cancer tissue to guide targeted therapy.	Formalin-Fixed Paraffin-Embedded (FFPE) Tumor Tissue Block or Biopsy Slides	5–7 working days from specimen receipt	6,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["EGFR mutations", "BRAF mutations", "ALK rearrangements", "ROS1 rearrangements", "MET mutations", "PD-L1 protein expression"] Parameters [{"name": "EGFR", "reference_range": null}, {"name": "BRAF", "reference_range": null}, {"name": "ALK", "reference_range": null}, {"name": "ROS1", "reference_range": null}, {"name": "MET", "reference_range": null}, {"name": "PD-L1", "reference_range": null}] Preparation [] Indications ["Diagnosis of advanced non-small cell lung cancer (NSCLC)", "Guidance for targeted therapy or immunotherapy decisions"] Measurement technique Confirm with laboratory Codes LOINC: 104196-4 ICD-10: C34.90 Clinical summary This test identifies specific genetic mutations and protein expressions in lung cancer tissue to guide targeted therapy.
TEST-2823 OncoPro NCCN Lung Cancer Panel Test This test evaluates genomic alterations in 15+ NCCN-recommended genes relevant to lung cancer.	20 mL Whole Blood in two Streck tubes	35 working days	13,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Genomic alterations (mutations, amplifications, deletions)", "Tumor Mutational Burden (TMB)", "Microsatellite Instability (MSI)", "Drug-sensitivity annotations"] Parameters [] Preparation ["No fasting required.", "Inform the team of any anticoagulant therapy."] Indications ["Diagnosis of lung cancer", "Treatment planning for lung cancer", "Monitoring for resistance mutations"] Measurement technique Confirm with laboratory Codes LOINC: 96984-7 ICD-10: C34.9, Z85.1 Clinical summary This test evaluates genomic alterations in 15+ NCCN-recommended genes relevant to lung cancer.
TEST-49 OncoPro NCCN Lung Cancer Panel with PD-L1 Test This test evaluates clinically relevant genetic alterations and PD-L1 expression in lung cancer using a liquid biopsy.	Blood (Liquid Biopsy)	35 working days from sample receipt	15,600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Genetic alterations (mutations, amplifications, etc.)", "PD-L1 expression"] Parameters [] Preparation ["No fasting or special dietary preparation is needed.", "Mandatory completion of the OncoPro Liquid Biopsy Clinical Information Form (Form 32) is required prior to sample collection."] Indications ["Diagnosis of lung cancer", "Guiding targeted therapy selection", "Guiding immunotherapy selection", "Monitoring treatment response (potential)"] Measurement technique Confirm with laboratory Codes LOINC: 91847-7 ICD-10: C34.90 Clinical summary This test evaluates clinically relevant genetic alterations and PD-L1 expression in lung cancer using a liquid biopsy.
TEST-2792 ONCOPRO® LUNG BASIC PANEL Test This diagnostic test evaluates key genetic mutations (EGFR, KRAS, ALK, ROS1) in lung cancer tissue to guide targeted therapy.	Formalin-Fixed Paraffin-Embedded (FFPE) Tumor Tissue Block – Archival Specimen	3 Business Days (Mon/Thu collection, Fri/Tue report)	1,600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["EGFR mutations", "KRAS mutations", "ALK rearrangements", "ROS1 mutations"] Parameters [] Preparation ["No special fasting or medication adjustments are needed prior to tissue collection."] Indications ["Newly diagnosed non-small cell lung cancer (NSCLC)"] Measurement technique Confirm with laboratory Codes LOINC: 21631-8 ICD-10: C34.90 Clinical summary This diagnostic test evaluates key genetic mutations (EGFR, KRAS, ALK, ROS1) in lung cancer tissue to guide targeted therapy.

Category overview

Lung Cancer Panel: overview

A lung cancer diagnosis requires immediate, highly specific molecular and protein profiling to unlock the most effective, advanced biological therapies available today. Representing a critical offering within our Histology and Oncology services, the Lung Cancer Panel microscopically evaluates your biopsied lung tissue for crucial predictive markers—such as EGFR, ALK, ROS1, and PD-L1. By leveraging state-of-the-art immunohistochemical and molecular technology, this expansive cellular screening helps pinpoint the tumor's exact vulnerabilities, safely guiding your healthcare provider in prescribing highly personalized targeted therapies, customized immunotherapies, and aggressive precision oncology care. Widely respected for specialized cancer diagnostics across top diagnostic labs in Dubai and the UAE, DNA Labs ensures absolute patient confidentiality, uncompromising analytical precision, and prompt, reliable turnaround times for time-sensitive cases. Protect your respiratory future—schedule your lung cancer panel testing in UAE, coordinate a secure clinical sample transfer, or consult our specialized oncology experts today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.